“Rimonabant is an anorectic anti-obesity drug developed by Sanofi-Aventis. It is marketed as Acomplia in the UK and EU. It has not got FDA (Food and Drug Administration) approval for sale in US. When Rimonabant gets approval from it for sale in US it migh…
Related posts: